The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
Written by
in
Appointments and Executive Changes, Centers for Disease Control and Prevention, Drugs (Pharmaceuticals), Food and Drug Administration, Government Employees, Health and Human Services Department, Kennedy, Robert F Jr, Makary, Marty, Rare and Orphan Diseases, Regulation and Deregulation of Industry, Trump, Donald J, United States Politics and Government